IFNAR1: Interferon alpha/beta receptor 1
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa).
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Anifrolumab | Approved | Interferon-alpha/beta receptor alpha chain antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Immunodeficiency 106, susceptibility to viral infections
- 0.70
- Chronic hepatitis B virus infection
- 0.61
- Melanoma
- 0.61
- Neoplasm
- 0.61
- Hepatitis B virus infection
- 0.61
- Chronic hepatitis C virus infection
- 0.60
- Hepatitis C virus infection
- 0.60
- Acquired polycythemia vera
- 0.58
- HIV infectious disease
- 0.52
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- IFNAR1
Drugs and mechanisms are from ChEMBL CHEMBL1887 (CC BY-SA 3.0). Gene name, function (UniProt P17181, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets